Gene · 3913
NIH grants2,633
NIH grants whose papers are about the gene, through NIH's grant-paper links.
801 to 820 of 2,633
Download this page as JSON| Grant | Title | LAMB2 papers | Newest fiscal year |
|---|---|---|---|
| R01ES028615 | Investigating the effectiveness of COVID-19 testing choices, community engagement, and culturally-embedded mHealth literacy delivery in a medically-underserved, community-based sample | 1 | 2022 |
| R01ES029212 | Placental Functional Networks Linking Developmental Pesticide Exposure and Offspring Neurodevelopment | 1 | 2022 |
| R01ES029280 | Environmental Exposures, AHR Activation, and Placental Origins of Development | 1 | 2022 |
| R01EY015313 | Novel Immunotoxin and IGF Therapy for Strabismus | 1 | 2022 |
| R01EY028667 | Noninvasive assessment of the cornea by diffusion OCT | 1 | 2022 |
| R01EY030774 | Novel approaches for corneal haze/fibrosis elimination | 1 | 2022 |
| R01GM108711 | Integrative multivariate association and genomic analyses | 1 | 2022 |
| R01HD094380 | Mechanisms of actions(s) of simvastatin in uterine leiomyoma | 1 | 2022 |
| R01HL056067 | T-Cell Targeting for GVHD | 1 | 2022 |
| R01HL061322 | Sarcoglycan in Myopathy and Muscle Membrane Stability | 1 | 2022 |
| R01HL096062 | Activation of the beta-3 integrins: Role of the Kindlins | 1 | 2022 |
| R01HL119374 | Endogenous suppression of integrin signaling | 1 | 2022 |
| R01HL120046 | Bioengineering a chimeric human lung | 1 | 2022 |
| R01HL124106 | Nanoscience of Self 2.0: blocking CD47 recognition by phagocytes in blood & solid tumor clearance | 1 | 2022 |
| R01HL136759 | Mechanisms and Treatment of Cardiac and Skeletal Muscular Dysfunction in Barth Syndrome | 1 | 2022 |
| R01HL143348 | Molecular Mechanisms of Flow-dependent Arterial Remodeling in Peripheral Arterial Disease | 1 | 2022 |
| R01HL144741 | Role of Protein Phosphatase 2A in Aortic Aneurysm | 1 | 2022 |
| R01HL146530 | Molecular Basis of Hypoxia-Induced Excessive Erythrocytosis | 1 | 2022 |
| R01HL147662 | Novel Molecular Target to Prevent Maturation Failure of Arteriovenous Fistula | 1 | 2022 |
| R01HL148059 | A Multi-Omics Approach to Discover Metabolic Critical Quality Attributes for Cardiomyocyte Biomanufacturing | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3913/grants?page=41